Diphenhydramine dosage and effects
Pro Research Analysisby 
Searched over 200M research papers
Diphenhydramine Dosage: Standard and Overdose Levels
Diphenhydramine is commonly used as an antihistamine, with typical adult oral doses ranging from 25 mg to 50 mg per administration. In children, dosing is adjusted by weight and age, with single doses ranging from 6.25 mg to 50 mg, and the drug is generally well-tolerated across age groups when used as directed. Mild somnolence is the most common side effect at therapeutic doses in children and adolescents, and no significant differences in drug clearance were observed after adjusting for body size and age . In adults, a single 25 mg dose produces minimal to undetectable effects on sedation, mood, or memory, regardless of age or gender .
Effects at Therapeutic Doses: Drowsiness and Cognitive Impairment
At standard doses (25–50 mg), diphenhydramine can cause drowsiness and mild cognitive impairment. A 50 mg dose leads to significant feelings of drowsiness for up to 6 hours and measurable mental impairment for about 2 hours, as shown by driving simulation and cognitive testing . These effects are dose-dependent, with drowsiness occurring at lower blood concentrations than cognitive impairment, but both are related to the same pharmacological action . In direct comparison with non-sedating antihistamines, a 50 mg dose of diphenhydramine significantly increases drowsiness and impairs attention and response time .
Postoperative and Clinical Use: Analgesic and Antiemetic Effects
Diphenhydramine has been studied for its potential to improve postoperative recovery due to its analgesic and antiemetic properties. However, intravenous doses of 25 mg and 50 mg given before surgery did not improve overall quality of recovery compared to placebo. The 50 mg dose did reduce the incidence of postoperative nausea, but this did not translate into a significant improvement in patient-centered recovery outcomes .
Pharmacokinetics: Absorption, Metabolism, and Elimination
After a single 100 mg oral dose in adults, peak plasma levels are reached in 2–4 hours, with concentrations ranging from 81 to 159 ng/ml and a half-life of about 6–7 hours . Multiple 50 mg doses throughout the day result in similar peak levels. The drug is metabolized in the liver, and about half of the dose is excreted in the urine as metabolites . Pharmacokinetic studies in overdose cases (900–1200 mg) show that plasma concentrations can reach around 1000–1300 ng/ml within 3 hours, but even at these high levels, severe liver toxicity is uncommon, though some increase in bilirubin may occur .
Toxicity and Overdose: Dose-Dependent Risks
Diphenhydramine toxicity is clearly dose-dependent. Mild symptoms such as drowsiness, dry mouth, rapid heartbeat, and nausea are common at lower overdose levels. Moderate symptoms, including confusion, hallucinations, and heart rhythm disturbances, typically occur at doses above 0.3 grams (300 mg). Severe symptoms—such as delirium, psychosis, seizures, and coma—are most likely when ingested doses exceed 1.0 gram (1000 mg). The risk of seizures and coma increases significantly at doses above 1.5 grams (1500 mg). Hospitalization is recommended for patients who ingest more than 1.0 gram due to the risk of severe complications .
Animal Studies and Safety Margins
Animal studies show that repeated high doses of diphenhydramine (alone or combined with caffeine) can cause reversible adverse effects such as reduced appetite and liver function changes. The no-observed-adverse-effect level (NOAEL) in rats was 51 mg/kg/day, and in dogs, it was 28.3 mg/kg/day for males and 5.66 mg/kg/day for females, indicating a relatively wide safety margin in controlled settings . In dogs, single intravenous or intramuscular doses of 1–2 mg/kg did not cause adverse effects or changes in behavior, and plasma concentrations exceeded those considered therapeutic in humans .
Conclusion
Diphenhydramine is generally safe at recommended doses, with drowsiness being the most common side effect. Cognitive impairment can occur at higher therapeutic doses, and the risk of severe toxicity increases sharply with overdose, especially above 1.0 gram. The drug’s pharmacokinetics are consistent across age groups and show linearity even at high doses. Hospitalization is advised for significant overdoses due to the risk of life-threatening symptoms.
Sources and full results
Most relevant research papers on this topic
Dose-ranging effect of systemic diphenhydramine on postoperative quality of recovery after ambulatory laparoscopic surgery: a randomized, placebo-controlled, double-blinded, clinical trial.
Diphenhydramine does not provide dose-ranging improvements on postoperative quality of recovery after ambulatory laparoscopic gynecologic surgery, with only 50 mg dose showing a decrease in postoperative nausea.
Pharmacokinetics and Pharmacodynamics of Diphenhydramine 25 mg in Young and Elderly Volunteers
Single 25-mg oral doses of diphenhydramine show no age or gender-related differences in pharmacokinetics and produce essentially undetectable pharmacodynamic effects in both young and elderly volunteers.
Effects of fexofenadine, diphenhydramine, and placebo on performance of the test of variables of attention (TOVA).
Diphenhydramine 50mg significantly decreased omission errors and response time on the Test of Variables of Attention (TOVA) and increased self-reported drowsiness compared to placebo.
DOI